329 related articles for article (PubMed ID: 26297673)
21. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in COPD.
Kirkham PA; Barnes PJ
Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
[TBL] [Abstract][Full Text] [Related]
23. Oxidant metabolism in chronic obstructive pulmonary disease.
Boots AW; Haenen GR; Bast A
Eur Respir J Suppl; 2003 Nov; 46():14s-27s. PubMed ID: 14621103
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF).
Vlahos R; Bozinovski S; Hamilton JA; Anderson GP
Pharmacol Ther; 2006 Oct; 112(1):106-15. PubMed ID: 16716406
[TBL] [Abstract][Full Text] [Related]
25. Future treatments for chronic obstructive pulmonary disease and its comorbidities.
Barnes PJ
Proc Am Thorac Soc; 2008 Dec; 5(8):857-64. PubMed ID: 19017741
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress-based therapeutics in COPD.
Barnes PJ
Redox Biol; 2020 Jun; 33():101544. PubMed ID: 32336666
[TBL] [Abstract][Full Text] [Related]
27. Chronic obstructive pulmonary disease and comorbidities.
Decramer M; Janssens W
Lancet Respir Med; 2013 Mar; 1(1):73-83. PubMed ID: 24321806
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
Dailah HG
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
[TBL] [Abstract][Full Text] [Related]
29. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
[TBL] [Abstract][Full Text] [Related]
30. [Comorbidities in COPD].
de Miguel Díez J; García TG; Maestu LP
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
[TBL] [Abstract][Full Text] [Related]
31. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
32. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
Rahman I
Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
[TBL] [Abstract][Full Text] [Related]
33. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.
Thomson NC
Curr Opin Pharmacol; 2018 Jun; 40():1-8. PubMed ID: 29223018
[TBL] [Abstract][Full Text] [Related]
34. Assessing Lung Inflammation and Pathology in Preclinical Models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Wang H; Bozinovski S
Methods Mol Biol; 2023; 2691():97-109. PubMed ID: 37355540
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant therapeutic targets in COPD.
Rahman I; Kilty I
Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
[TBL] [Abstract][Full Text] [Related]
36. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.
Macnee W; Rahman I
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S58-65. PubMed ID: 10556172
[TBL] [Abstract][Full Text] [Related]
37. Site of mitochondrial reactive oxygen species production in skeletal muscle of chronic obstructive pulmonary disease and its relationship with exercise oxidative stress.
Puente-Maestu L; Tejedor A; Lázaro A; de Miguel J; Alvarez-Sala L; González-Aragoneses F; Simón C; Agustí A
Am J Respir Cell Mol Biol; 2012 Sep; 47(3):358-62. PubMed ID: 22493009
[TBL] [Abstract][Full Text] [Related]
38. [Comorbidities in COPD: a new challenge in clinical practice].
Couillard A; Veale D; Muir JF
Rev Pneumol Clin; 2011 Jun; 67(3):143-53. PubMed ID: 21665077
[TBL] [Abstract][Full Text] [Related]
39. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
Lin JL; Thomas PS
COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
[TBL] [Abstract][Full Text] [Related]
40. [Chronic obstructive pulmonary disease and cardiovascular diseases--'cardiopulmonary continuum'].
Batura-Gabryel H; Grabicki M
Pneumonol Alergol Pol; 2014; 82(6):590-6. PubMed ID: 25339571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
